Abstract
To investigate properties of yellow lupine cytosolic cyclophilin, an expression vector pET15CYP was constructed. The CyP cDNA (GenBank accession no.Y16088) reveals an open reading frame of 172 amino acids with the conserved tryptophan residue at position 128 and an insertion of seven amino acids spanning positions 48-54. Yellow lupine cyclophilin, purified after expression in E. coli cells, exhibits peptidyl-prolyl cis/trans isomerase activity when assayed with a synthetic oligopeptide. We have demonstrated that the recombinant cyclophilin is able to interact with nucleic acids, both single and double stranded DNA fragments as well as RNA.
Keywords: Cyclophilin, Isomerase, Protein expression, DNA-protein interaction
Protein & Peptide Letters
Title: Yellow Lupine Cyclophilin Interacts with Nucleic Acids
Volume: 15 Issue: 7
Author(s): Katarzyna Nuc, Krzysztof Lesniewicz, Przemyslaw Nuc and Ryszard Slomski
Affiliation:
Keywords: Cyclophilin, Isomerase, Protein expression, DNA-protein interaction
Abstract: To investigate properties of yellow lupine cytosolic cyclophilin, an expression vector pET15CYP was constructed. The CyP cDNA (GenBank accession no.Y16088) reveals an open reading frame of 172 amino acids with the conserved tryptophan residue at position 128 and an insertion of seven amino acids spanning positions 48-54. Yellow lupine cyclophilin, purified after expression in E. coli cells, exhibits peptidyl-prolyl cis/trans isomerase activity when assayed with a synthetic oligopeptide. We have demonstrated that the recombinant cyclophilin is able to interact with nucleic acids, both single and double stranded DNA fragments as well as RNA.
Export Options
About this article
Cite this article as:
Nuc Katarzyna, Lesniewicz Krzysztof, Nuc Przemyslaw and Slomski Ryszard, Yellow Lupine Cyclophilin Interacts with Nucleic Acids, Protein & Peptide Letters 2008; 15 (7) . https://dx.doi.org/10.2174/092986608785133726
DOI https://dx.doi.org/10.2174/092986608785133726 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Trials are Often False Positive: A Review of Simple Methods to Control This Problem
Current Clinical Pharmacology In Silico and 3D QSAR Studies of Natural Based Derivatives as Xanthine Oxidase Inhibitors
Current Topics in Medicinal Chemistry Crosstalk between Behavior and Immune System During the Prodromal Stages of Alzheimer`s Disease
Current Pharmaceutical Design Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Signal Transduction Therapy with Rationally Designed Kinase Inhibitors
Current Signal Transduction Therapy New Pharmacological Perspectives and Therapeutic Potential of PPAR-γ Agonists
Current Pharmaceutical Design Review of Pediatric Uveitis
Current Pediatric Reviews Treatment of Psoriasis: A Comprehensive Review of Entire Therapies
Current Drug Safety Clopidogrel, Aspirin and Proton Pump Inhibition after Percutaneous Valve Implants: An Update
Current Pharmaceutical Design Fungal Bioactive Compounds in Pharmaceutical Research and Development
Current Bioactive Compounds Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology Modulation of P2 Receptors on Pancreatic β-cells by Agonists and Antagonists: A Molecular Target for Type 2 Diabetes Treatment
Current Diabetes Reviews Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery
Current Drug Research Reviews Editorial
Current Radiopharmaceuticals Olanzapine Loaded Cationic Solid Lipid Nanoparticles for Improved Oral Bioavailability
Current Nanoscience Scaffold-based Screening and Molecular Dynamics Simulation Study to Identify Two Structurally Related Phenolic Compounds as Potent MMP1 Inhibitors
Combinatorial Chemistry & High Throughput Screening The TRAIL to Viral Pathogenesis: The Good, the Bad and the Ugly
Current Molecular Medicine Specificity of Binding in Protein Kinases
Current Enzyme Inhibition Activated Synovial Macrophages as Targets for Osteoarthritis Drug Therapy
Current Drug Targets Targeting Fibrosis in Systemic Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets